Estimating the impact of HIV PrEP regimens containing long-acting injectable cabotegravir or daily oral tenofovir disoproxil fumarate/emtricitabine among men who have sex with men in the United States: a mathematical modelling study for HPTN 083

BACKGROUND: The HPTN 083 trial demonstrated superiority of HIV pre-exposure prophylaxis (PrEP) containing long-acting injectable cabotegravir (CAB) to daily oral tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) among men who have sex with men (MSM). We compared the potential population-level im...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitchell, Kate M., Boily, Marie-Claude, Hanscom, Brett, Moore, Mia, Todd, Jeffery, Paz-Bailey, Gabriela, Wejnert, Cyprian, Liu, Albert, Donnell, Deborah J., Grinsztejn, Beatriz, Landovitz, Raphael J., Dimitrov, Dobromir T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950652/
https://www.ncbi.nlm.nih.gov/pubmed/36844011
http://dx.doi.org/10.1016/j.lana.2022.100416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950652/
https://www.ncbi.nlm.nih.gov/pubmed/36844011
http://dx.doi.org/10.1016/j.lana.2022.100416

Ejemplares similares